"A systematic review undertaken in 2017 of the coverage of interventions to prevent and manage HIV and hepatitis C among PWID showed that needle and syringe programmes were available in only 52 per cent of countries where injecting drug use was reported, while opioid substitution therapy was confirmed to be available in 48 per cent of countries worldwide.
Data, statistics and information regarding HIV/AIDS related to injection drug use
"The joint UNODC/WHO/UNAIDS/World Bank estimate for the number of people who inject drugs (PWID) for 2014 is 11.7 million (range: from 8.4 to 19.0 million), or 0.25 per cent (range: 0.18-0.40 per cent) of the population aged 15-64.
(New HIV Infections Among Youths in the US, by Transmission Method) "In 2010, of the estimated 47,500 new HIV infections, 12,200 (25.7%) were among youths (10,100 [82.8%] among males and 2,100 [17.2%] among females). An estimated 7,000 (57.4%) newly infected youths were blacks/African Americans (5,600 males and 1,400 females), 2,390 (19.6%) were Hispanics/Latinos (2,100 males and 290 females), and 2,380 (19.5%) were whites (2,100 males and 280 females) (Figure 2).
(HIV Prevalence Among Youth) "In 2009, youths (defined in this report as persons aged 13–24 years), who represented 21% of the U.S. population, comprised 6.7% of persons living with HIV. More than half (59.5%) were unaware of their infection, the highest for any age group (1)."
(AIDS Diagnoses in the US, by Transmission Method and Gender) "From 2009 through 2013, the annual number of infections classified as stage 3 (AIDS) among adult and adolescent males with HIV infection attributed to male-to-male sexual contact, injection drug use, male-to-male sexual contact and injection drug use, or heterosexual contact decreased. The number of infections classified as stage 3 (AIDS) among adult and adolescent females with HIV infection attributed to injection drug use or heterosexual contact decreased."
(Trends in HIV Deaths in the US, by Transmission Method and Gender) "Sex and transmission category: From 2010 through 2014, the rates of deaths for male and female adults and adolescents decreased. The number of deaths among males with diagnosed HIV infection attributed to male-to-male sexual contact, to injection drug use, to male-to-male sexual contact and injection drug use, or to heterosexual contact decreased. The number of deaths among females with infection attributed to injection drug use or to heterosexual contact decreased.
(Global Estimated Prevalence of IDU-Related HIV, 2011) "Of the estimated 14.0 million (range: 11.2 million to 22.0 million) people who inject drugs worldwide, UNODC estimates that 1.6 million (range: 1.2 million to 3.9 million) are living with HIV. That represents a global prevalence of HIV of 11.5 per cent among people who inject drugs.15
(Method of Infection, AIDS Diagnoses 2008-2011) "From 2008 through 2011, the annual number of infections classified as stage 3 (AIDS) among adult and adolescent males with HIV infection attributed to male-to-male sexual contact increased. The numbers of stage 3 (AIDS) classifications among males with infection attributed to injection drug use, to male-to-male sexual contact and injection drug use, and to heterosexual contact decreased.
(HIV/AIDS Death Rate in Prisons, 2001-2010) "The rate of AIDS-related deaths in state prisons among inmates ages 15 to 54 declined sharply between 2001 and 2009, compared to the more modest decline observed among the same age group in the U.S. general population. As a result, the AIDS-related death rate in state prisons fell below the rate in the U.S. general population in 2009.
(Cases and Deaths in Inmate Population, 2001-2010) "Between 2001 and 2010, the estimated number of inmates with HIV/AIDS declined by 16%, and the number of AIDS-related deaths in prison declined by 77% (not shown in table) resulting in declines in the rates of HIV/AIDS and AIDS-related deaths among all inmates and those with HIV/AIDS. At yearend 2001, the estimated rate of HIV/AIDS among state and federal prison inmates was 194 HIV/AIDS cases per 10,000 inmates. By yearend 2010, the estimated rate was 146 cases per 10,000.